Short talk: µSTASIS - Assessment of human microbiota stability across longitudinal samples
µSTASIS - Assessment of human microbiota stability across longitudinal samples Pedro Sánchez-Sánchez Institute for Research in Biomedicine (IRB) Barcelona Abstract Microbiome research is moving forward increasingly faster mainly due to the continuous implementations developed throughout the years to gain more detail in taxonomy and functional surveys. For example, this rapid advance is reflected by the diversity of cutting-edge microbiome-based therapeutics such as fecal microbiota transplantation, prebiotics or engineered symbiotic bacteria. So, along the years, microbiome data captured as a snapshot in time has uncovered the interindividual variability of human microbiota meanwhile changes in individualized microbiota emerge as predictors of clinical outcomes and disease forecast.